︎
We are proud to see the strong results of our science-based growth vision in Turkey’s pharmaceutical and dietary supplement sector. Our AlyorsGroup companies—Nuvita İlaç A.Ş. Turkishtime—have been ranked among Turkey’s strongest companies in the “Turkey R&D 500” survey in both the R&D expenditure and number of projects categories.
In the Turkey R&D 500 Survey, Nuvita made a significant leap to rank among the top 250 companies. With 38 active projects, a tenfold increase in R&D investment since 2021, and 11 patent applications filed over the past two years, the company has positioned itself among the top 100 firms in Turkey with the highest number of R&D projects.
As our CEO Yunus Emre Alimoğlu has emphasised, this success is a natural outcome of our long-term vision rooted in science and innovation. As Orzax, part of the Alyors Group which exports to over 50 countries, we continue to strengthen our strong position within Turkey’s health technology ecosystem through our NUVİTA facilities, which produce to pharmaceutical standards, and our sustainability approach.